Cancer treatment as a double-edged sword
Even with today’s safer and more targeted anti-cancer drugs, scientists have been unable to satisfactorily…
Author ONA Editor
ONA Editor
The ONA Editor curates oncology news, views and reviews from Australia and around the world for our readers. In aggregated content, original sources will be acknowledged in the article footer.
New study combines laser therapy and craniotomy to treat large, previously inoperable brain tumours
A new paper in the journal Neurosurgical Focus finds the use of laser beneficial for the removal…
Common prostate cancer treatment linked to later dementia
A new retrospective study of patient medical records suggests that men with prostate cancer who…
Glioblastoma cholesterol consumption may be a metabolic target
A Ludwig Cancer Research study has identified a metabolic vulnerability in the aggressive and incurable…
Breast cancer resistance to tamoxifen elucidated
Researchers have discovered that a protein found naturally in cells that provides some protection from…
CEO of Australian Prostate Cancer Research Clinches Global Oncology Prize
CEO of Australian Prostate Cancer Research (APCR), Mark Harrison, Melbourne, has clinched a global AUD $32,840 oncology grant for his role in…
Viral particles support prophylactic vaccination against breast cancer
Artificial structures of tumour antigens, so-called mimotopes, applied in vaccinations of cancer patients can trigger…
Psychological intervention tackles fear of melanoma recurrence
A new psychological intervention has been shown to significantly reduce melanoma survivors’ fear of their…
ESMO 2016: Longer disease-free survival in phase III trial of sunitinib as adjuvant treatment for kidney cancer
A phase III trial of sunitinib has met its primary endpoint of disease-free survival for…
ESMO 2016: Single-arm trials for early access to cancer drugs
Although randomised clinical trials (RCTs) remain the gold standard for evaluating the benefit/risk of cancer…